Core Viewpoint - The cryptocurrency market is positioned for potential recovery, with traditional financial institutions beginning to adopt blockchain solutions, which may drive prices higher. Solana and Chainlink are highlighted as two cryptocurrencies that could benefit from this trend [1]. Group 1: Solana - Solana experienced a decline of 35.7% in 2025, ending the year at $124.52, but previously reached an all-time high of $293.31 in January [3]. - The current price of Solana is $86.82, with a market cap of $49 billion [4]. - Analysts predict that the stablecoin market could grow to $4 trillion by 2030 from over $300 billion currently, indicating a potential increase of over 1,000% [5]. - Solana's speed and low transaction costs position it favorably for on-chain transactions, and it ranks second to Ethereum in developer activity and total value locked, suggesting strong future growth potential [6]. Group 2: Chainlink - Chainlink finished 2025 down nearly 40%, closing at $12.19, with a current price of $8.80 and a market cap of $6.2 billion [7][8]. - The price range for Chainlink over the past five years has been between $5.30 and $52.70, indicating it is currently near the lower end of this range, which presents a strong rebound potential [8]. - As an oracle coin, Chainlink provides essential data for smart contracts, which are crucial for the functioning of decentralized applications. Increased demand for stablecoins may drive the need for reliable data sources, enhancing Chainlink's relevance [9]. Group 3: Market Context - The cryptocurrency market faced a significant shock in October 2025, with over $19 billion in leveraged positions liquidated, impacting market momentum [11]. - Recent legislative changes in 2025 have removed some barriers to adoption, suggesting a potential shift in market dynamics as traditional finance embraces blockchain technology [12].

Core Insights - Interlink Electronics, Inc. has appointed Mark Duarte as the Director of Business Development for North America to support its organic growth strategy across the Americas [1][2] Group 1: Appointment and Role - Mark Duarte will play a crucial role in implementing Interlink's strategic growth plan and expanding its footprint across the Americas [2] - Duarte brings over 30 years of experience, including 22 years in sales and strategic planning, with a strong track record of exceeding revenue targets [3] Group 2: Previous Experience - Prior to joining Interlink, Duarte was the Senior Sales Manager at Linxens Healthcare, where he focused on aligning sales efforts with corporate growth strategies and secured multi-year contracts [3] - Duarte also served as the Director of Medical Sales at East West MFG., where he established the company as a premier contract manufacturer in the medical device market [4] Group 3: Company Overview - Interlink Electronics is a leading provider of sensor technology and printed electronic solutions, with 40 years of experience serving diverse markets including medical, industrial, automotive, and IoT [5] - The company operates from multiple locations, including its headquarters in Fremont, California, and manufacturing facilities in Shenzhen, China; Irvine, Scotland; and Barnsley, England [6]

Core Insights - Interlink Electronics, Inc. has appointed Darren Whittaker as the European Business Development Director to support its organic growth strategy in Europe [1] - Whittaker brings over 20 years of sales experience in high-tech sectors, having previously increased revenue by 8.3 times at Teledyne FLIR [2] - The company aims to drive significant growth across its technology offerings globally, as stated by CEO Steven Bronson [4] Company Overview - Interlink Electronics is a leader in sensor technology and printed electronics solutions, with 40 years of experience serving diverse markets including medical, industrial, automotive, wearables, and IoT [4] - The company operates from multiple locations, including its headquarters in Fremont, California, and manufacturing facilities in Shenzhen, China, Irvine, Scotland, and Barnsley, England [5] - Interlink's expertise encompasses materials science, manufacturing, embedded electronics, firmware, and software, allowing for tailored solutions for customers [4]

Partnerships & Integrations - Coinbase 选择 Chainlink 作为安全解决方案，将其 Coinbase Wrapped Assets 带到新的区块链上 [1] - 这被认为是朝着使加密货币领域更加统一迈出的巨大一步 [1] Technology & Adoption - 行业预测 2025 年将是 CCIP（Cross-Chain Interoperability Protocol 跨链互操作协议） 采用之年 [1] - 预计明年会有更多发展 [1]

RT XSwap 🔗 (@xswap_link)We’re super excited to take part in @chainlink Rewards Season 1.Eligible LINK stakers - big welcome to the XSwap community. It's time to allocate your Cubes.Let’s give you a closer look at what we’re building. 🧵 ...

Financial Performance - Revenue for Q3 2025 increased by 11% year-over-year to $3.0 million, compared to $2.7 million in Q3 2024[6] - Gross profit for Q3 2025 was $1.238 million, a 12% increase from $1.105 million in the same period last year[7] - Net loss for Q3 2025 improved to $336,000 from a net loss of $523,000 in Q3 2024[8] - Adjusted EBITDA for Q3 2025 was $(62,000), an improvement from $(248,000) in the prior-year period[9] - Revenue for Q3 2025 was $2,959,000, an increase of 10.8% compared to $2,671,000 in Q3 2024[22] - Gross profit for Q3 2025 was $1,238,000, up from $1,105,000 in Q3 2024, reflecting a gross margin improvement[22] - Net loss for Q3 2025 was $336,000, compared to a net loss of $523,000 in Q3 2024, indicating a reduction in losses[22] - Adjusted EBITDA for Q3 2025 was $(62,000), an improvement from $(248,000) in Q3 2024[25] - The company reported a net loss applicable to common stockholders of $436,000 in Q3 2025, down from $623,000 in Q3 2024[22] - Earnings per share for Q3 2025 was $(0.03), an improvement from $(0.04) in Q3 2024[22] Operational Highlights - The company secured two significant SBIR grants totaling $375,000 for advancing food safety technologies[6] - Interlink signed a Letter of Intent to acquire a U.K.-based engineering and manufacturing company, enhancing its European presence[6] - Total operating expenses for Q3 2025 were $1,551,000, slightly down from $1,581,000 in Q3 2024[22] - Engineering, research and development expenses decreased to $354,000 in Q3 2025 from $486,000 in Q3 2024, showing a focus on cost management[22] - Selling, general and administrative expenses increased to $1,197,000 in Q3 2025 from $1,095,000 in Q3 2024, indicating higher operational costs[22] Financial Position - Gross margin for Q3 2025 was 41.8%, a 40-basis-point increase from the previous year[8] - The company issued a 50% common stock dividend to enhance liquidity and shareholder value[4] - Total assets as of September 30, 2025, were $12.081 million, down from $13.116 million at the end of 2024[20] - Total stockholders' equity decreased to $9.632 million from $10.493 million at the end of 2024[20] - The weighted average common shares outstanding for Q3 2025 was 14,813,000, slightly up from 14,793,000 in Q3 2024[22]

Revenue Performance - Revenue for Q3 2025 was $2,959,000, representing a 10.8% increase from $2,671,000 in Q3 2024[112]. - For the nine months ended September 30, 2025, total revenue was $9,037,000, a 4.0% increase from $8,693,000 in the same period of 2024[123]. Profitability - Gross profit for Q3 2025 was $1,238,000, with a gross margin of 41.8%, up from $1,105,000 and 41.4% in Q3 2024[116]. - Gross profit for the nine months ended September 30, 2025, was $3,725,000, representing a gross margin of 41.2%, slightly down from 42.1% in 2024[124]. Market Segmentation - Medical market revenue increased by 88.9% to $1,084,000 in Q3 2025, while industrial market revenue decreased by 27.9% to $888,000[114]. - Medical market revenue decreased by 7.7% to $2,829,000, while industrial market revenue increased by 12.5% to $3,154,000[123]. Expenses - Engineering, research and development expenses decreased by 27.2% to $354,000 in Q3 2025, down from $486,000 in Q3 2024[117]. - Engineering, research and development expenses decreased by 26.8% to $1,572,000, accounting for 12.7% of revenue[125][127]. - Selling, general and administrative expenses increased by 9.3% to $1,197,000 in Q3 2025, compared to $1,095,000 in Q3 2024[118]. - Selling, general and administrative expenses were $3,670,000, or 40.6% of revenue, showing a slight increase of 1.1% compared to the previous year[128]. - Total operating expenses for Q3 2025 were $1,551,000, a decrease from $1,581,000 in Q3 2024[112]. Net Loss - The company reported a net loss of $336,000 in Q3 2025, compared to a net loss of $523,000 in Q3 2024[112]. Cash and Working Capital - As of September 30, 2025, the company had cash and cash equivalents of $3.0 million and working capital of $4.9 million, with no indebtedness[131]. - Net cash provided by operating activities was $244,000 for the nine months ended September 30, 2025, compared to a cash used of $144,000 in 2024[133][134]. Strategic Initiatives - The company has expanded its technology platforms through acquisitions, including Calman and Conductive Transfers, enhancing its product offerings in printed electronics and wearable technology[104]. - The company plans to explore strategic relationships with technology institutes to support growth initiatives[107]. - The company maintains a global presence with manufacturing facilities in Shenzhen, California, Scotland, and England, controlling 100% of the manufacturing and shipping process[106]. Other Income and Tax - Other income for the nine months ended September 30, 2025, was $33,000, compared to $29,000 in 2024, with interest income of $18,000 and foreign currency transaction gains of $15,000[129]. - Income tax expense was 2.1% of pre-tax income for the nine months ended September 30, 2025, down from 4.0% in 2024[130]. Stock Issuance - The company entered into an At-The-Market Issuance Sales Agreement allowing for the sale of up to $6,000,000 in common stock, with approximately $5.8 million available for sale as of September 30, 2025[138].

Core Insights - Interlink Electronics reported an 11% year-over-year revenue increase to $2.959 million for Q3 2025, marking the second consecutive quarter of double-digit growth [6][7][9] - The company is focusing on organic growth and has a strengthened M&A pipeline, positioning itself for transformative growth in 2026 [5][7] Financial Performance - Revenue for Q3 2025 was $2.959 million, up from $2.671 million in Q3 2024, driven by higher shipments of force-sensing products and printed electronics [6][8] - Gross profit increased to $1.238 million, a 12% rise from $1.105 million in the same quarter last year, with a gross margin of 41.8% [6][9] - The net loss for Q3 2025 was $336,000, an improvement from a net loss of $523,000 in Q3 2024 [6][9] Strategic Initiatives - The company converted all outstanding Series A Convertible Preferred Stock into common stock and issued a 50% common stock dividend, enhancing liquidity and shareholder alignment [4][7] - Interlink secured two significant U.S. government SBIR grants totaling $375,000 to advance food safety and quality monitoring technologies [3][7] - A Letter of Intent was signed to acquire a U.K.-based engineering and manufacturing company, expanding Interlink's European presence [7] Market Position and Outlook - Interlink is entering 2026 with strong momentum across product lines and a growing base of strategic partnerships, aiming for consistent profitability and scale [5][7] - The company continues to evaluate a growing pipeline of acquisition opportunities that align with long-term shareholder value [7]

Core Insights - UBS has completed the first on-chain redemption of a tokenized fund using Chainlink's Digital Transfer Agent, marking a significant step in integrating blockchain technology with the global fund industry valued at $100 trillion [1][2] - The transaction involved the UBS USD Money Market Investment Fund Token (uMINT), which is built on the Ethereum blockchain [1] - This achievement highlights the potential of smart contract-based technologies to enhance fund operations and improve the investor experience, according to UBS' group chief operating and technology officer [2][3] Industry Developments - The transaction is part of UBS Tokenize, the bank's platform for blockchain-based financial products, indicating a broader trend towards tokenized finance [3] - By automating functions such as order-taking, execution, and settlement, the technology aims to reduce operational complexity and processing time within the $100 trillion global fund industry [4] - A recent pilot project demonstrated Chainlink's ability to connect existing bank systems to blockchains via Swift, allowing banks to utilize blockchain technology without needing to overhaul their legacy systems [5]

.@SolvProtocol is enhancing their use of Chainlink CCIP for cross-chain SolvBTC transfers by incorporating @symbioticfi for additional cryptoeconomic guarantees.https://t.co/FEtdbrQCLqSymbiotic LINK and SOLV vaults will back a Symbiotic-powered network designed to monitor and flag potential anomalies when SolvBTC is transferred cross-chain.This development is made possible by CCIP’s extensive support for modular security, which enables token developers to incorporate additional custom safeguards into how th ...